In studies using a xenograft model, CysLT1R antagonists (montelukast and ZM198,615) inhibited proliferation and induced apoptosis of tumor cells, resulting in reduced size of the inoculated tumor [57,93]. The gene discussed is CYSLTR1; the disease is neoplasm.